Key facts
- JANUS HENDERSON GROUP PLC filed SCHEDULE 13G/A for TRAVERE THERAPEUTICS, INC Common Stock (TVTX).
- Disclosed ownership: 12%.
- Date of event: 30 Sep 2025.
JANUS HENDERSON GROUP PLC - 30 Sep 2025 SCHEDULE 13G/A Report for TRAVERE THERAPEUTICS, INC Common Stock (TVTX)
- Filing manager
- JANUS HENDERSON GROUP PLC
- Reporting owner
- JANUS HENDERSON GROUP PLC
- Symbol
- TVTX
- Shares outstanding
- 89,072,773 shares
- Disclosed ownership
- 10,599,660 shares
- Ownership
- 12%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 12:49:52 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 07 Aug 2025
- SEC
- View on sec.gov
Key filing fact
JANUS HENDERSON GROUP PLC disclosed 12% ownership in TRAVERE THERAPEUTICS, INC Common Stock (TVTX) on 30 Sep 2025.
Change
- Previous schedule filing date: 07 Aug 2025.
- Current filing was accepted on 14 Nov 2025, 12:49.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 12% | 10,599,660 | 0 | 10,599,660 | Kristin Mariani | Head of North America Compliance, CCO |
CIK / CUSIP context first